Curi RMB Capital’s Cellectis CLLS Stock Holding History

Curi RMB Capital’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-28,639	Closed	-$510K	–	609
2020 Q2	$510K	Buy	+28,639	New	+$436K	0.02%	403

Other funds holding CLLS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Curi RMB Capital's CLLS Position: Q3 2020 in Review

Curi RMB Capital sold out of Cellectis (CLLS) in Q3 2020, closing a stake of 28,639 shares — an estimated $510K sold.

Curi RMB Capital first reported a position in CLLS in Q2 2020 and held it in 1 quarter. The position peaked at $510K in Q2 2020. 74 funds tracked by Wall St. Rank hold CLLS as of Q3 2020.

Curi RMB Capital reported no remaining Cellectis position as of Q3 2020 after selling out during the quarter.
Curi RMB Capital sold 28,639 Cellectis shares in Q3 2020, an estimated $510K.
Curi RMB Capital first reported a position in Cellectis in Q2 2020 and held it in 1 quarter.
Curi RMB Capital's Cellectis position peaked at $510K in Q2 2020.
74 funds tracked by Wall St. Rank held Cellectis as of Q3 2020.

Based on Curi RMB Capital's 13F filing for Q3 2020, filed 10 Nov 2020.